[Prevalence and in vitro antimicrobial susceptibility patterns of Acinetobacter baumannii strains in a Moroccan...

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Clinical Pharmacy

Background:

• Acinetobacter baumannii is a significant opportunistic pathogen.
• Nosocomial infections caused by multidrug-resistant bacteria are a growing concern.
• Understanding antimicrobial susceptibility patterns is crucial for effective treatment.

Purpose of the Study:

• To determine the clinical characteristics of Acinetobacter baumannii infections.
• To assess the current antimicrobial resistance profile of Acinetobacter baumannii strains.
• To evaluate resistance patterns in relation to intensive care unit (ICU) settings.

Main Methods:

• Retrospective analysis of 754 Acinetobacter baumannii isolates collected between January 2003 and December 2005.
• Identification of prevalent sample sources, including bronchial swabs and blood cultures.
• Antimicrobial susceptibility testing using standard microbiological methods.

Main Results:

• A high prevalence of Acinetobacter baumannii was observed, with over 50% of isolates originating from ICUs.
• Significant resistance rates were recorded for commonly used antibiotics: 91% to cefotaxime, 50.3% to ceftazidime, and 42.6% to imipenem.
• High resistance was also noted for aminoglycosides (17.9%-72.1%), ciprofloxacin (65.8%), and trimethoprim-sulfamethoxazole (75.8%), with significantly higher rates in ICUs (p<0.05).

Conclusions:

• Acinetobacter baumannii demonstrates alarming levels of resistance to current antibiotics, especially within intensive care units.
• The findings underscore the critical need for developing and implementing robust strategies to combat Acinetobacter baumannii-associated nosocomial infections.
• Continuous monitoring of antimicrobial resistance patterns is essential for guiding therapeutic decisions and infection control measures.